Identification of a novel NAMPT inhibitor by CRISPR/Cas9 chemogenomic profiling in mammalian cells
David Estoppey(Novartis (Switzerland)), Dominic Hoepfner(Novartis (Switzerland)), Annick Waldt(Novartis (Switzerland)), Guglielmo Roma(Novartis (Switzerland)), Walter Carbone(Novartis (Switzerland)), Chantale T. Guy, John Reece-Hoyes(University of Massachusetts Chan Medical School), Rachel Cuttat(Novartis (Switzerland)), Markus Schirle(Novartis (United States)), Judith Knehr(Novartis (Switzerland)), Gregory McAllister, Bertran Gerrits(Novartis (Switzerland)), Jason R. Thomas, Kevin Xie, Xuewen Pan(Baylor College of Medicine), Sven Schuierer(Novartis (Switzerland)), Nadire Ramadan(Novartis (United States)), Jeffrey Hewett(Harvard University), Zinger Yang(Broad Institute), Malini Varadarajan, Alicia Lindeman, Tewis Bouwmeester(Institute of Pathology Celle), Gregory R. Hoffman, Qiong Wang, Xin Chen, Elizabeth Frias(Novartis (United States)), Carsten Russ(Broad Institute), Edmund Harrington(Novartis (Switzerland))
Cited by 39
Related Papers
A Draft Sequence of the Neandertal Genome
|Science|2010|4.6k
Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing
|Nature Biotechnology|2009|1.5k